
结论很明确:这个市场不值得进入。 当前只有1个可识别的新品牌样本,而且新品牌新增产品成功率是0%,不是健康增长,而是几乎没有可复制的入场路径;同时市场没有出现新的品牌扩张信号,反而是老品牌BIOESTHE在吃存量。
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
结论很明确:这个市场不值得进入。 你手上的50万CNY预算表面上够做单个ASIN的前期起步,但市场里真正能跑通的样本太少,而且新产品成功率为0%,新进入者几乎没有可复制的正面案例;对大品牌和小品牌来说,这都不是一个高胜率市场。
证据很直接:目前可识别的产品里,盈利率只有50%,但新发布产品盈利率是0%;去年8月上新的BIOESTHE新ASIN B0FN7ZF3HM 直接失败,而同品牌老款B0F62YV1H3还能做到17.99美元售价、29.48%利润率、月销100、月收179,900美元,说明市场不是靠“通用款”就能赢,而是靠老品牌/老链接的既有势能在撑。 按规则看,10%以上才算可盈利,15%以上才算比较体面;这类市场里新款却完全没跑出来,说明竞争已经非常偏向存量和品牌势能。更关键的是,BIOESTHE属于老品牌却在新发布上做成了100%非盈利,说明新进场即使有品牌基础也未必能过线;而你这类预算还没算研发、品牌和认证,实际压力只会更大。市场时间趋势也没有给出扩张信号,近几年新产品释放几乎为空,说明不是健康增长,而是低活跃、低增量环境。
给你的判断:大品牌也不该贸然进,小业务更不该进。 这里没有看到“<300 reviews/年”的真实小商家成功样本,唯一可参考的盈利案例B0F62YV1H3是老品牌成熟款,不能拿来当小商家模板;相反,失败款B0FN7ZF3HM更像是标准的通用品,说明这个类目里“容易做”的路径已经被压扁了。若硬要找对标,只能看BIOESTHE的旧款B0F62YV1H3,但那是老品牌打法,不适合作为小商家入场案例。结论:不要进入。
Alternative solutions may pose a risk to your investment in certain markets.
不建议进入,这个市场对新卖家并不友好。 现有数据里,只有 1 个可识别盈利样本、1 个亏损样本,市场新款盈利率是 0%,而且月度趋势里 2025 年只看到 1 个新发布且未盈利,说明新进入并没有跑通;这不是适合小卖家试错的环境。
这不是一个适合进入的市场。当前数据只覆盖到 2 个样本,其中 1 个盈利、1 个亏损,表面成功率 50%,但真正的问题是:新上架产品只有 1 个,而且它是老品牌 BIOESTHE 的旧品牌延伸,不是小商家可复制的样本;新产品 B0FN7ZF3HM 直接失败,且是公开通用款,说明这类打法已经很难赚到钱。
证据很直接:盈利款 B0F62YV1H3 价格 $17.99,月销 100,月营收 $1799,月利润 $530.35,利润率 29.48%,早期投入约 $2582.46,其中广告就占 $580.80;而同品牌新款 B0FN7ZF3HM 作为新发布产品却没有销量、没有利润,属于失败样本。再看品牌层面,BIOESTHE 总共 2 个产品,1 盈利 1 亏损,成功率 50%;但新产品里 100% 都是老品牌在试新,而不是新品牌真实突围。产品对比也说明了原因:B0F62YV1H3 有更明确的“304 不锈钢双支冰球、耐摔、不漏液、家用冷敷”差异点,B0FN7ZF3HM 则只是常见双头冷感棒,差异不足。市场趋势上,2025 年只看到 1 个新发布且失败,短期看不到健康的新品牌增长,反而更像老品牌在用已有品牌力吃市场。
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
![]() | B0F62YV1H3 | BIOESTHE | 2025-07-19 | Yes | $17.99 | 100pcs | $1799.0 | 29.48% | $530.35 |
New products with negative profitability ranked by lowest profit value. Only includes newly released products classified as non-profitable.
![]() | B0FN7ZF3HM | BIOESTHE | 2025-08-21 | No | $- | -pcs | $- | -% | $- |
结论很直接:这个市场不值得进入,当前信号是“已被老品牌主导、纯新品几乎无成功案例”,对大品牌和小商家都不是好市场。 现有数据里,新品成功率是0%,新品失败率是100%,而且唯一看到的新品来自老品牌 BIOESTHE,说明不是新玩家能轻松切入的市场。
What is the ratio of profitable products
What is the ratio of different brands owning all nonprofitable new products
这个市场不适合进入,核心原因是新品牌几乎没有成功样本,且最近的新品表现是负面的。 目前只有 1 个可识别的新品牌案例 BIOESTHE,2025 年新上架的 B0FN7ZF3HM 直接失败;相反,旧品牌 BIOESTHE 的老款 B0F62YV1H3 才能卖动,说明这个类目更偏向“老品牌吃红利”,不是新品牌可轻松切入的市场。
证据很直接:2025 年新增新品里,BIOESTHE 只有 1 个失败款,没有任何可算作新品牌成功的案例;时间趋势上 2022-2024 年几乎没有新增,2025 年才出现一个新品牌却立刻失败,说明不是健康增量,而是低频试错。 利润数据也不支持新入场:能看见的盈利样本只有老款 B0F62YV1H3,售价 $17.99,月销 100,月营收约 $179,900,利润率 29.48%;但同品牌新品 B0FN7ZF3HM 没有销量、没有收入、直接失败。产品形态上,两款都只是公开市场常见的 304 不锈钢冰球/冷感棒,B0FN7ZF3HM 没有明显差异化,说明不是“创新驱动”,更像普通跟卖式尝试。按 500,000 CNY 预算,你勉强能覆盖单个 ASIN 的前期成本,但这不足以解决研发、品牌和认证成本;在这种环境下,新品没有看到可复制的成功路径。
结论:不要进入。 对大品牌来说,这里也不是值得重投的市场;对小品牌来说,更没有真实成功案例可跟,只会遇到“旧品牌更强 + 新品失手”的局面。建议你只把 BIOESTHE 的老款 B0F62YV1H3 当作“老品牌既有产品”参考,不要把它当成新品牌入场模板。
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2026 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2025/7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2025/9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |